Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beata Lecka-Czernik

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Idrugs : the Investigational Drugs Journal|November 4, 2010
Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitusBeata Lecka-Czernik
Bone|July 16, 2011
Marrow fat metabolism is linked to the systemic energy metabolismBeata Lecka-Czernik
PPAR Research|January 30, 2007
PPARs and Bone MetabolismBeata Lecka-Czernik
Diabetologia|April 24, 2017
Diabetes, bone and glucose-lowering agents: basic biologyBeata Lecka-Czernik
Current Osteoporosis Reports|September 3, 2010
Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosisBeata Lecka-Czernik
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Bone as a target of type 2 diabetes treatmentBeata Lecka-Czernik
Clinical Reviews in Bone and Mineral Metabolism|April 2, 2013
Safety of Anti-Diabetic Therapies on BoneBeata Lecka-Czernik
Current Osteoporosis Reports|April 29, 2010
PPARs in bone: the role in bone cell differentiation and regulation of energy metabolismBeata Lecka-Czernik
Archives of Biochemistry and Biophysics|June 24, 2014
Bone and fat: a relationship of different shadesBeata Lecka-Czernik, Lance A Stechschulte
PPAR Research|January 30, 2007
Resolving the Two "Bony" Faces of PPAR-gammaBeata Lecka-Czernik, Larry J Suva
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Idrugs : the Investigational Drugs Journal|November 4, 2010
Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitusBeata Lecka-Czernik
Bone|July 16, 2011
Marrow fat metabolism is linked to the systemic energy metabolismBeata Lecka-Czernik
PPAR Research|January 30, 2007
PPARs and Bone MetabolismBeata Lecka-Czernik
Diabetologia|April 24, 2017
Diabetes, bone and glucose-lowering agents: basic biologyBeata Lecka-Czernik
Current Osteoporosis Reports|September 3, 2010
Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosisBeata Lecka-Czernik
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Bone as a target of type 2 diabetes treatmentBeata Lecka-Czernik
Clinical Reviews in Bone and Mineral Metabolism|April 2, 2013
Safety of Anti-Diabetic Therapies on BoneBeata Lecka-Czernik
Current Osteoporosis Reports|April 29, 2010
PPARs in bone: the role in bone cell differentiation and regulation of energy metabolismBeata Lecka-Czernik
Archives of Biochemistry and Biophysics|June 24, 2014
Bone and fat: a relationship of different shadesBeata Lecka-Czernik, Lance A Stechschulte
PPAR Research|January 30, 2007
Resolving the Two "Bony" Faces of PPAR-gammaBeata Lecka-Czernik, Larry J Suva
Pageof 7